Softwr

Research · head to head

Genedata vs Overleaf

Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Free plan
No
Overleaf logo

Overleaf

Research

Online collaborative LaTeX editor with templates and publisher submission links

From
Free
Free plan
Yes

The short version

  • Overleaf starts at $13/mo; Genedata prices on request.
  • Only Genedata lists instrument integration; only Overleaf lists browser-based LaTeX editing.
  • Where Overleaf falls short: free plan allows one collaborator per project and 24 hours of document history.
  • Prices and features on this page were last checked on 20 November 2026.

How do Genedata and Overleaf differ?

Genedata and Overleaf differ on starting price (On request against Free), pricing model (Quote against Freemium) and free tier (No against Yes). Only the attributes on which Genedata and Overleaf actually diverge.

Attributes where Genedata and Overleaf differ
AttributeGenedataOverleaf
Starting priceOn requestFree
Pricing modelQuoteFreemium
Free tierNoYes
PlatformsWeb, Self-hostedWeb
Founded19972011

Identical on both: category (Research).

Which features does each one have?

They share no listed features; 8 appear only for Genedata and 8 only for Overleaf. Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

Only in Overleaf

  • Browser-based LaTeX editing
  • Real-time collaboration
  • Journal and conference templates
  • Direct publisher submission links
  • Document history
  • Track changes (paid plans)
  • Reference search (paid plans)
  • AI assistant (paid plans)

What is each one used for?

Overleaf is most often brought in for writing journal papers. The jobs each tool is most often brought in to do.

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot Overleaf
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot Overleaf
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot Overleaf
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot Overleaf

Overleaf

  • Writing journal papersnot Genedata
  • Collaborating on thesesnot Genedata
  • Preparing conference submissionsnot Genedata
  • Group LaTeX licences for departmentsnot Genedata

Where do Genedata and Overleaf fall short?

Overleaf's most cited limit: free plan allows one collaborator per project and 24 hours of document history. Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case

Overleaf

  • Free plan allows one collaborator per project and 24 hours of document history
  • Track changes and integrations are not on the Free plan
  • Offline editing is limited to 2 minutes on Free and 10 on Standard and Pro
  • Student plan is limited to students at degree-granting institutions
  • Needs LaTeX knowledge; it is not a word processor

How much do Genedata and Overleaf cost?

Genedata is priced on request; Overleaf has a free plan, with paid plans from $13/mo. Plan by plan below, from each vendor's own pricing page.

Genedata

On request
  • Genedata platform licenceOn request
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

Overleaf

Free
  • FreeFree
  • Student$13/mo
  • Standard$25/mo
  • Pro$45/mo

Which should you pick?

Choose Genedata if

  • You need screener.
  • You work on Web, Self-hosted.
  • You also want biologics.

Choose Overleaf if

  • You need browser-based latex editing.
  • You want to start without paying.
  • You also want real-time collaboration.

Questions people ask

Is Genedata or Overleaf better?
Neither clearly leads. Genedata starts at On request and Overleaf at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Genedata or Overleaf?
Overleaf has a free tier; the other does not. Paid plans start at On request for Genedata and Free for Overleaf.
Does Genedata or Overleaf run on more platforms?
Genedata runs on Web, Self-hosted. Overleaf runs on Web.
Can I use Overleaf for free?
Yes. Overleaf has a free tier, so you can try it without paying. Genedata starts at On request.
What is Genedata best used for?
Genedata is most often used for a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale, a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets, a process development group standardising bioprocess run data across sites for modelling and scale-up, a cro delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelines. Of those, a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale and a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets are not what Overleaf is typically brought in for.
What can Genedata do that Overleaf cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist. Overleaf covers Browser-based LaTeX editing, Real-time collaboration, Journal and conference templates, Direct publisher submission links.

Answered from the vendors’ own pages

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

Overleaf: How much does Overleaf cost?

The pricing page lists Student at 13 dollars per month, Standard at 25 and Pro at 45, with yearly prices of 98, 199 and 399 dollars. A Free plan is also listed.

Source
Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

Overleaf: Is there a free plan?

Yes. It gives unlimited projects but one collaborator per project, 5 AI uses per day and 24 hours of document history.

Source
Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

Overleaf: Is Overleaf open source?

Wikipedia says the software is open source under the AGPLv3 licence, while the main website runs a proprietary version of it. The Free plan is a limited hosted tier.

Source
Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

Overleaf: Who started Overleaf?

Wikipedia says it began in 2011 as WriteLaTeX, founded by mathematicians John Hammersley and John Lees-Miller, and acquired ShareLaTeX on 20 July 2017. Digital Science made a strategic investment in 2014.

Source
Share

Related pages

Other head to heads